|
NDUFA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.42929999952446E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.12029995969732E-09 |
| Normal-vs-Stage2 |
8.500600E-01 |
| Normal-vs-Stage3 |
3.210300E-04 |
| Normal-vs-Stage4 |
1.638060E-02 |
| Stage1-vs-Stage2 |
9.833700E-02 |
| Stage1-vs-Stage3 |
2.314000E-01 |
| Stage1-vs-Stage4 |
9.352000E-02 |
| Stage2-vs-Stage3 |
2.505200E-01 |
| Stage2-vs-Stage4 |
4.087200E-01 |
| Stage3-vs-Stage4 |
5.195800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.17949999556677E-08 |
| Normal-vs-AfricanAmerican |
7.067400E-01 |
| Normal-vs-Asian |
9.079400E-01 |
| Caucasian-vs-AfricanAmerican |
2.707500E-02 |
| Caucasian-vs-Asian |
3.810000E-01 |
| AfricanAmerican-vs-Asian |
9.973200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80257999999878E-05 |
| Normal-vs-Female |
2.26129999999491E-05 |
| Male-vs-Female |
9.430200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.937600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.40000000037332E-07 |
| Normal-vs-Age(61-80Yrs) |
1.74745000000032E-05 |
| Normal-vs-Age(81-100Yrs) |
6.794000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.238400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.180400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.092800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.613200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.866000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.071860E-02 |
| Normal-vs-Grade 2 |
1.43470000002477E-06 |
| Normal-vs-Grade 3 |
1.60523999999107E-05 |
| Normal-vs-Grade 4 |
2.990200E-01 |
| Grade 1-vs-Grade 2 |
6.348600E-01 |
| Grade 1-vs-Grade 3 |
3.303200E-01 |
| Grade 1-vs-Grade 4 |
1.023560E-01 |
| Grade 2-vs-Grade 3 |
2.315200E-01 |
| Grade 2-vs-Grade 4 |
1.358060E-02 |
| Grade 3-vs-Grade 4 |
5.625700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62503344114384E-12 |
| Normal-vs-ccB subtype |
2.396900E-03 |
| ccA subtype-vs-ccB subtype |
1.74423999999007E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.789470E-04 |
| Normal-vs-N1 |
1.655170E-01 |
| N0-vs-N1 |
8.468400E-01 |
|
|
